Market Cap (In USD)
3.07 Million
Revenue (In USD)
1.07 Million
Net Income (In USD)
-10.49 Million
Avg. Volume
8804.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0013-0.0309
- PE
- -
- EPS
- -
- Beta Value
- 5.147
- ISIN
- CA91360F1099
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Nicholas Peter Karos
- Employee Count
- -
- Website
- https://universalibogaine.com
- Ipo Date
- 2022-03-01
- Details
- Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
More Stocks
-
4317Ray Corporation
4317
-
001390KG Chemical Corporation
001390
-
CXU
-
NAZARANazara Technologies Limited
NAZARA
-
7036eMnet Japan.co.ltd.
7036
-
ATBHFAston Bay Holdings Ltd.
ATBHF
-
20MICRONS20 Microns Limited
20MICRONS
-
KTHN